Clinical Trials

Showing trials with last updates posted in 2026.

NCT05542121 | COMPLETED | NA
27 participants

Rehab CARES In USA: Clinical Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2022-06-01
Completion:
2025-08-30
Conditions
  • Stroke
  • Hemiplegia
Interventions
  • DEVICE
  • OTHER
No Results Yet
NCT05491980 | ACTIVE_NOT_RECRUITING
72 participants

Florida Cerebrovascular Disease Biorepository and Genomics Center

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-03
Start Date:
2022-08-02
Completion:
2030-06-30
Conditions
  • Cerebrovascular Disease
  • Ischemic Stroke
  • Transient Ischemic Attack
  • Intracerebral Hemorrhage
  • Aneurysmal Subarachnoid Hemorrhage
  • Vascular Dementia
  • Anoxic Brain Injury
  • Unruptured Intracranial Aneurysm
  • Carotid Artery Stenosis Symptomatic
  • Asymptomatic Carotid Artery Stenosis
  • Non-Aneurysmal Perimesencephalic Subarachnoid Haemorrhage
  • Cerebral Venous Thrombosis
  • Moyamoya Disease
  • Fibromuscular Dysplasia
  • Subarachnoid Hemorrhage
  • Leukoaraiosis
  • Arteriovenous Fistula
  • Reversible Cerebral Vasoconstriction Syndrome
  • CADASIL
No Results Yet
NCT05386719 | RECRUITING | NA
450 participants

Cardiometabolic Screening Program

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2022-06-03
Completion:
2027-08-01
Conditions
  • Breast Cancer
  • Early-stage Breast Cancer
Interventions
  • OTHER
  • BEHAVIORAL
No Results Yet
NCT05257473 | ACTIVE_NOT_RECRUITING
80 participants

Defining Endpoints in Becker Muscular Dystrophy

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-03
Start Date:
2022-04-13
Completion:
2026-09-30
Conditions
  • Becker Muscular Dystrophy
  • Muscular Dystrophies
  • Muscular Dystrophy in Children
  • Muscular Dystrophy, Becker
No Results Yet
NCT05256225 | RECRUITING | PHASE3
360 participants

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2022-11-16
Completion:
2027-10-31
Conditions
  • Endometrial Carcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Dedifferentiated Carcinoma
  • Endometrial Endometrioid Adenocarcinoma
  • Endometrial Mixed Cell Adenocarcinoma
  • Endometrial Serous Adenocarcinoma
  • Endometrial Undifferentiated Carcinoma
  • Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor
Interventions
  • PROCEDURE
  • DRUG
  • RADIATION
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page